Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease

Anne H. Agler, Ronald Crystal, Jason G. Mezey, Jennifer Fuller, Chuan Gao, Joyanna G. Hansen, Patricia A. Cassano

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Antioxidant nutritional status is hypothesized to influence chronic obstructive pulmonary disease (COPD) susceptibility and progression. Although past studies relate antioxidants to gene expression, there are no data in patients with COPD. This study investigated the hypothesis that antioxidant status is compromised in patients with COPD, and antioxidant-responsive genes differentially express in a similar pattern. Lung tissue samples from patients with COPD were assayed for vitamin E and gene expression. Selenium and vitamin E were assayed in corresponding plasma samples. Discovery based genome-wide expression analysis compared moderate, severe, and very severe COPD (GOLD II-IV) patients to mild and at-risk/normal (GOLD 0-I). Hypotheses-driven analyses assessed differential gene expression by disease severity for vitamin E-responsive and selenium-responsive genes. GOLD II-IV COPD patients had 30% lower lung tissue vitamin E levels compared to GOLD 0-I participants (p = 0.0082). No statistically significant genome-wide differences in expression by disease severity were identified. Hypothesis-driven analyses of 109 genes found 16 genes differentially expressed (padjusted < 0.05) by disease severity including 6 selenium-responsive genes (range in fold-change -1.39 to 2.25), 6 vitamin E-responsive genes (fold-change -2.30 to 1.51), and 4 COPD-associated genes. Lung tissue vitamin E in patients with COPD was associated with disease severity and vitamin E-responsive genes were differentially expressed by disease severity. Although nutritional status is hypothesized to contribute to COPD risk, and is of therapeutic interest, evidence to date is mainly observational. The findings reported herein are novel, and support a role of vitamin E in COPD progression.

Original languageEnglish
Pages (from-to)450-458
Number of pages9
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume10
Issue number4
DOIs
Publication statusPublished - 1 Aug 2013
Externally publishedYes

Fingerprint

Selenium
Vitamins
Chronic Obstructive Pulmonary Disease
Vitamin E
Genes
Antioxidants
Nutritional Status
Gene Expression
Lung
Disease Progression
Genome
Disease Susceptibility

Keywords

  • Antioxidants
  • COPD
  • Gene expression
  • Selenium
  • Tocopherol

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease. / Agler, Anne H.; Crystal, Ronald; Mezey, Jason G.; Fuller, Jennifer; Gao, Chuan; Hansen, Joyanna G.; Cassano, Patricia A.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, No. 4, 01.08.2013, p. 450-458.

Research output: Contribution to journalArticle

Agler, Anne H. ; Crystal, Ronald ; Mezey, Jason G. ; Fuller, Jennifer ; Gao, Chuan ; Hansen, Joyanna G. ; Cassano, Patricia A. / Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease. In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2013 ; Vol. 10, No. 4. pp. 450-458.
@article{9accf6ca3c484e64a3f2e7d16896df49,
title = "Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease",
abstract = "Antioxidant nutritional status is hypothesized to influence chronic obstructive pulmonary disease (COPD) susceptibility and progression. Although past studies relate antioxidants to gene expression, there are no data in patients with COPD. This study investigated the hypothesis that antioxidant status is compromised in patients with COPD, and antioxidant-responsive genes differentially express in a similar pattern. Lung tissue samples from patients with COPD were assayed for vitamin E and gene expression. Selenium and vitamin E were assayed in corresponding plasma samples. Discovery based genome-wide expression analysis compared moderate, severe, and very severe COPD (GOLD II-IV) patients to mild and at-risk/normal (GOLD 0-I). Hypotheses-driven analyses assessed differential gene expression by disease severity for vitamin E-responsive and selenium-responsive genes. GOLD II-IV COPD patients had 30{\%} lower lung tissue vitamin E levels compared to GOLD 0-I participants (p = 0.0082). No statistically significant genome-wide differences in expression by disease severity were identified. Hypothesis-driven analyses of 109 genes found 16 genes differentially expressed (padjusted < 0.05) by disease severity including 6 selenium-responsive genes (range in fold-change -1.39 to 2.25), 6 vitamin E-responsive genes (fold-change -2.30 to 1.51), and 4 COPD-associated genes. Lung tissue vitamin E in patients with COPD was associated with disease severity and vitamin E-responsive genes were differentially expressed by disease severity. Although nutritional status is hypothesized to contribute to COPD risk, and is of therapeutic interest, evidence to date is mainly observational. The findings reported herein are novel, and support a role of vitamin E in COPD progression.",
keywords = "Antioxidants, COPD, Gene expression, Selenium, Tocopherol",
author = "Agler, {Anne H.} and Ronald Crystal and Mezey, {Jason G.} and Jennifer Fuller and Chuan Gao and Hansen, {Joyanna G.} and Cassano, {Patricia A.}",
year = "2013",
month = "8",
day = "1",
doi = "10.3109/15412555.2012.761958",
language = "English",
volume = "10",
pages = "450--458",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Differential expression of vitamin e and selenium-responsive genes by disease severity in chronic obstructive pulmonary disease

AU - Agler, Anne H.

AU - Crystal, Ronald

AU - Mezey, Jason G.

AU - Fuller, Jennifer

AU - Gao, Chuan

AU - Hansen, Joyanna G.

AU - Cassano, Patricia A.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Antioxidant nutritional status is hypothesized to influence chronic obstructive pulmonary disease (COPD) susceptibility and progression. Although past studies relate antioxidants to gene expression, there are no data in patients with COPD. This study investigated the hypothesis that antioxidant status is compromised in patients with COPD, and antioxidant-responsive genes differentially express in a similar pattern. Lung tissue samples from patients with COPD were assayed for vitamin E and gene expression. Selenium and vitamin E were assayed in corresponding plasma samples. Discovery based genome-wide expression analysis compared moderate, severe, and very severe COPD (GOLD II-IV) patients to mild and at-risk/normal (GOLD 0-I). Hypotheses-driven analyses assessed differential gene expression by disease severity for vitamin E-responsive and selenium-responsive genes. GOLD II-IV COPD patients had 30% lower lung tissue vitamin E levels compared to GOLD 0-I participants (p = 0.0082). No statistically significant genome-wide differences in expression by disease severity were identified. Hypothesis-driven analyses of 109 genes found 16 genes differentially expressed (padjusted < 0.05) by disease severity including 6 selenium-responsive genes (range in fold-change -1.39 to 2.25), 6 vitamin E-responsive genes (fold-change -2.30 to 1.51), and 4 COPD-associated genes. Lung tissue vitamin E in patients with COPD was associated with disease severity and vitamin E-responsive genes were differentially expressed by disease severity. Although nutritional status is hypothesized to contribute to COPD risk, and is of therapeutic interest, evidence to date is mainly observational. The findings reported herein are novel, and support a role of vitamin E in COPD progression.

AB - Antioxidant nutritional status is hypothesized to influence chronic obstructive pulmonary disease (COPD) susceptibility and progression. Although past studies relate antioxidants to gene expression, there are no data in patients with COPD. This study investigated the hypothesis that antioxidant status is compromised in patients with COPD, and antioxidant-responsive genes differentially express in a similar pattern. Lung tissue samples from patients with COPD were assayed for vitamin E and gene expression. Selenium and vitamin E were assayed in corresponding plasma samples. Discovery based genome-wide expression analysis compared moderate, severe, and very severe COPD (GOLD II-IV) patients to mild and at-risk/normal (GOLD 0-I). Hypotheses-driven analyses assessed differential gene expression by disease severity for vitamin E-responsive and selenium-responsive genes. GOLD II-IV COPD patients had 30% lower lung tissue vitamin E levels compared to GOLD 0-I participants (p = 0.0082). No statistically significant genome-wide differences in expression by disease severity were identified. Hypothesis-driven analyses of 109 genes found 16 genes differentially expressed (padjusted < 0.05) by disease severity including 6 selenium-responsive genes (range in fold-change -1.39 to 2.25), 6 vitamin E-responsive genes (fold-change -2.30 to 1.51), and 4 COPD-associated genes. Lung tissue vitamin E in patients with COPD was associated with disease severity and vitamin E-responsive genes were differentially expressed by disease severity. Although nutritional status is hypothesized to contribute to COPD risk, and is of therapeutic interest, evidence to date is mainly observational. The findings reported herein are novel, and support a role of vitamin E in COPD progression.

KW - Antioxidants

KW - COPD

KW - Gene expression

KW - Selenium

KW - Tocopherol

UR - http://www.scopus.com/inward/record.url?scp=84880760566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880760566&partnerID=8YFLogxK

U2 - 10.3109/15412555.2012.761958

DO - 10.3109/15412555.2012.761958

M3 - Article

C2 - 23875740

AN - SCOPUS:84880760566

VL - 10

SP - 450

EP - 458

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 4

ER -